According to a study reported in the Journal of Urology, Thalidomide is associated with an increase in prostate specific antigen (PSA) progression-free survival in men with biochemically recurrent prostate cancer who are on intermittent androgen deprivation therapy (ADT). The study leader, Dr William Figg, from the National Institutes of Health in Bethesda, Maryland, said, "These [...]
I was recently reviewing current clinical trials and came across this one for men who have failed chemotherapy, what many of us view as the final treatment for advanced prostate cancer. It provides a potential opportunity to combine two different therapy agents (one old, mitoxantrone; one relatively new, ixabepilone). Both of these chemicals are known [...]
Sure, we need more research about prostate cancer, but fortunately we also gain from research into other cancers. The commonly referred to breast cancer genes, BRCA1 and BRCA2 might also increase a man’s risk for developing an aggressive strain of prostate cancer. According to a report in Reuters, men with prostate cancer who also carry [...]
Not only is having cancer a life changing experience, but it also is a life-long event. Once you have been diagnosed, even if you think that you are cured, you remain a cancer survivor until you die. Cancer is never cured it is only controlled. We all are constantly subject to having a recurrence and [...]
During the last two support meetings that Malecare has held in New York City, part of the conversation has turned to the topic of incontinence and diapers. We have a few members of the group who have had recent surgery and have been struggling with their inability to control their urine. Surgery, radiation and just [...]